Home
Live Updates
Japans Asahi Kasei puts up $1.06B offer to buy out Tarpeyo maker Calliditas : vimarsana.com
Japan's Asahi Kasei puts up $1.06B offer to buy out Tarpeyo maker Calliditas
Bolstered by a full FDA approval for its primary immunoglobulin A nephropathy (IgAN) treatment Tarpeyo, Calliditas has earned the attention of Japanese chemical giant Asahi Kasei.
Related Keywords
New York ,
United States ,
Sweden ,
Japan ,
Stockholm ,
Swedish ,
Japanese ,
Callidita Tarpeyo ,
Asahi Kasei ,
Stiftelsen Industrifonden ,
European Renal Association ,
Veloxis Pharmaceuticals ,
Nasdaq ,
Bay Area ,
Bionova Scientific ,
vimarsana.com © 2020. All Rights Reserved.